MoneyWorks4Me

Vista Pharmaceuticals informs about company updates

12 Feb 2018 Evaluate

Vista Pharmaceuticals has informed that the Company had an USFDA Inspection from 1st February to 9th February, 2018. Form 483 has been issued to the company with observations. The Company will respond to the observations in the next 15 working days.

The above information is a part of company’s filings submitted to BSE.

 

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..